Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
2001 1
2014 2
2016 1
2020 4
2021 6
2022 6
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review.
Yan Y, Fu J, Kowalchuk RO, Wright CM, Zhang R, Li X, Xu Y. Yan Y, et al. Among authors: wright cm. Transl Lung Cancer Res. 2022 Feb;11(2):307-322. doi: 10.21037/tlcr-22-108. Transl Lung Cancer Res. 2022. PMID: 35280316 Free PMC article. Review.
BACKGROUND AND OBJECTIVE: Radiation-induced lung injury (RILI) is often found in thoracic tumor patients after thoracic radiation therapy, and influences patient quality of life. ...KEY CONTENT AND FINDINGS: RILI is a constantly developing and changing process inclu …
BACKGROUND AND OBJECTIVE: Radiation-induced lung injury (RILI) is often found in thoracic tumor patients after thoracic radiation
Palliative Radiotherapy for Diffuse Large B-cell Lymphoma.
Wright CM, Koroulakis AI, Baron JA, Chong EA, Tseng YD, Kurtz G, LaRiviere M, Venigalla S, Jones JA, Maity A, Mohindra P, Plastaras JP, Paydar I. Wright CM, et al. Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):650-658. doi: 10.1016/j.clml.2021.05.007. Epub 2021 May 19. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34127417 Review.
Is Host Metabolism the Missing Link to Improving Cancer Outcomes?
Wright CM, Shastri AA, Bongiorno E, Palagani A, Rodeck U, Simone NL. Wright CM, et al. Cancers (Basel). 2020 Aug 19;12(9):2338. doi: 10.3390/cancers12092338. Cancers (Basel). 2020. PMID: 32825010 Free PMC article. Review.
For the past 100 years, oncologists have relentlessly pursued the destruction of tumor cells by surgical, chemotherapeutic or radiation oncological means. Consistent with this focus, treatment plans are typically based on key characteristics of the tumor itself such as dis …
For the past 100 years, oncologists have relentlessly pursued the destruction of tumor cells by surgical, chemotherapeutic or radiation
Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Lee DY, Baron J, Wright CM, Plastaras JP, Perl AE, Paydar I. Lee DY, et al. Among authors: wright cm. Front Oncol. 2021 May 10;11:671514. doi: 10.3389/fonc.2021.671514. eCollection 2021. Front Oncol. 2021. PMID: 34046361 Free PMC article.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingival MS. ...We believe that …
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation
Tubarial salivary gland sparing with proton therapy.
Wright CM, Lee DY, Kim M, Barsky AR, Teo BK, Lukens JN, Swisher-McClure S, Lin A. Wright CM, et al. Med Dosim. 2022 Autumn;47(3):222-226. doi: 10.1016/j.meddos.2022.03.001. Epub 2022 Apr 12. Med Dosim. 2022. PMID: 35428548
Here, we show superior dosimetric sparing of the tubarial salivary glands with proton radiation therapy (PRT) compared to intensity-modulated radiotherapy (IMRT) for patients treated postoperatively for human papillomavirus (HPV)-associated oropharyngeal squamous cell carc …
Here, we show superior dosimetric sparing of the tubarial salivary glands with proton radiation therapy (PRT) compared to intensity-m …
Dosimetric Results for Adjuvant Proton Radiation Therapy of HPV-Associated Oropharynx Cancer.
Wright CM, Baron J, Lee DY, Kim M, Barsky AR, Teo BK, Lukens JN, Swisher-McClure S, Lin A. Wright CM, et al. Int J Part Ther. 2021 Nov 24;8(4):47-54. doi: 10.14338/IJPT-D-21-00018. eCollection 2022 Spring. Int J Part Ther. 2021. PMID: 35530184 Free PMC article.
Here, we report our institutional experience and dosimetric results with adjuvant proton radiation therapy (PRT) versus intensity-modulated radiotherapy (IMRT) for Human Papilloma Virus (HPV)-associated OPSCC. ...
Here, we report our institutional experience and dosimetric results with adjuvant proton radiation therapy (PRT) versus intensity-mod …
Stricter Postoperative Oropharyngeal Cancer Radiation Therapy Normal Tissue Dose Constraints Are Feasible.
Su W, Wright CM, Lee DY, Kim M, Anstadt EJ, Teo BK, Carlson DJ, Lukens JN, Eisbruch A, Lin A. Su W, et al. Among authors: wright cm. Pract Radiat Oncol. 2022 Jul-Aug;12(4):e282-e285. doi: 10.1016/j.prro.2022.03.006. Epub 2022 Mar 15. Pract Radiat Oncol. 2022. PMID: 35304348
Doses delivered to organs at risk were compared with recommended dose constraints from a recent cooperative group head and neck cancer trial of radiation therapy to 60 Gy. We applied validated and published NTCP models for dysphagia, dysgeusia, esophagitis, oral mucositis, …
Doses delivered to organs at risk were compared with recommended dose constraints from a recent cooperative group head and neck cancer trial …
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
Wright CM, Dreyfuss AD, Baron JA, Maxwell R, Mendes A, Barsky AR, Doucette A, Svoboda J, Chong EA, Jones JA, Maity A, Plastaras JP, Paydar I. Wright CM, et al. Adv Radiat Oncol. 2022 Jul 3;7(6):101016. doi: 10.1016/j.adro.2022.101016. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420208 Free PMC article.
PURPOSE: To report objective response rates (ORR), time to local failure (TTLF), and overall survival (OS) among patients with relapsed or refractory diffuse large B-cell lymphoma after salvage- or palliative-intent radiation therapy (RT) and to investigate whether outcome …
PURPOSE: To report objective response rates (ORR), time to local failure (TTLF), and overall survival (OS) among patients with relapsed or r …
21 results